Physician profile
Steven A Freeman
NPI 1497770176
$2,093.67
in general payments reported to CMS, 2019-2025
30 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $161 · 2021: $57.90 · 2022: $125 · 2023: $205 · 2024: $171 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $262.70 | 2019-2025 | Ozempic, Rybelsus, Tresiba |
| Pfizer INC. | $198.82 | 2019-2020 | |
| Lilly USA, LLC | $177.98 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.04 | 2019-2021 | |
| Amgen INC. | $144.59 | 2019-2024 | Otezla, Repatha, Prolia |
| Abbvie INC. | $139.10 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $103.25 | 2019-2023 | Vaxelis, Gardasil 9, Vaxneuvance |
| Glaxosmithkline, LLC. | $102.86 | 2019-2023 | Shingrix, Trelegy Ellipta |
| Vanda Pharmaceuticals INC. | $93.33 | 2025 | Fanapt, Hetlioz |
| Sanofi-Aventis U.S. LLC | $79.10 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $78.32 | 2025 | Uzedy, Austedo Xr |
| Boston Scientific Corporation | $70.90 | 2019-2024 | Watchman Flx, Watchman Access System |
| Astellas Pharma US INC | $60.94 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $51.98 | 2020-2023 | |
| Astrazeneca Pharmaceuticals LP | $39.63 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $35.47 | 2019 | |
| Allergan, INC. | $34.24 | 2019-2020 | |
| Sanofi Pasteur INC. | $33.33 | 2020-2023 | |
| Exact Sciences Corporation | $31.58 | 2024-2025 | Cologuard Collection Kit |
| Abiomed | $30.72 | 2024 | Impella |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.80 | 2019 | |
| Sequel Med Tech, LLC | $22.85 | 2025 | Twiist |
| Biohaven Pharmaceutical Holding Company LTD. | $22.80 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.44 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $17.88 | 2023 | |
| Ascensia Diabetes Care US INC. | $16.54 | 2025 | |
| Xeris Pharmaceuticals, INC. | $15.30 | 2025 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $14.21 | 2022 | |
| Lantheus Medical Imaging, INC. | $13.50 | 2025 | |
| Mylan Specialty L.P. | $8.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.